Valley Brook Capital Group, Inc. Pfizer Inc Transaction History

Valley Brook Capital Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $133,847 - $174,249	-3,398 Reduced 31.91%	7,250 $295,000
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $12,352 - $15,306	270 Added 2.6%	10,648 $551,000
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $19,625 - $25,210	-500 Reduced 4.6%	10,378 $446,000
Q2 2021 Jul 22, 2021	SELL	$35.91 - $40.68 $31,421 - $35,595	-875 Reduced 7.44%	10,878 $425,000
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $11,721 - $13,219	-350 Reduced 2.89%	11,753 $425,000
Q4 2020 Mar 19, 2021	BUY	$33.47 - $42.56 $405,087 - $515,103	12,103 New	12,103 $445,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Valley Brook Capital Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Valley Brook Capital Group, Inc. with notifications on news.